Day: December 28, 2020

VANCOUVER, Colombie-Britannique (Canada), 28 déc. 2020 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V : MMY et FSE : D7Q1, ci-après « Monument » ou la « Société ») a le plaisir d’annoncer que la transaction en vue de l’arrangement de coentreprise avec Odyssey Gold Ltd (ASX : ODY) a été conclue. ODY est désormais détenteur à 80 % du projet aurifère de Tuckanarra (ci-après « Tuckanarra »), ce qui laisse à Monument une participation à hauteur de 20 % d’intérêts de porteur non rémunérés.Le site de Tuckanarra est localisé dans le complexe aurifère de Murchison. Cet accord de coentreprise permet le déploiement immédiat de l’exploration à Tuckanarra et fournit à Monument l’opportunité de voir le futur minerai produit par ODY alimenter son usine de traitement aurifère de Burnakura.Lors de la clôture, Monument...

VANCOUVER, British Columbia, Dec. 28, 2020 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V:MMY und FSE:D7Q1) „Monument“ oder das „Unternehmen“ freut sich bekannt zu geben, dass es eine Joint-Venture-Vereinbarung (die „Transaktion“) mit Odyssey Gold Ltd (ASX:ODY) abgeschlossen hat; ODY besitzt damit 80 % des Tuckanarra-Goldprojekts („Tuckanarra“) und Monument verbleibt mit einer freien Beteiligung von 20 %.Tuckanarra befindet sich im Murchison-Goldfeld. Durch die JV-Vereinbarung kann die Erschießung von Tuckanarra sofort vorangetrieben werden und Monument erhält die Möglichkeit, das von ODY abgebaute Erz in der Burnakura-Goldverarbeitungsanlage zu verarbeiten.Beim Abschluss hat Monument eine erste Zahlung von 2.000.000 AUD$ erhalten. Weitere 2.000.000 AUD$ werden in den nächsten 6 Monate fällig.Eine erfolgsgebundene Meilensteinzahlung...

LAS VEGAS, Dec. 28, 2020 (GLOBE NEWSWIRE) — Marathon Patent Group, Inc. (NASDAQ:MARA) (“Marathon” or the “Company”), one of the largest enterprise Bitcoin self-mining companies in North America, has entered into a contract with Bitmain to purchase 70,000 Antminer S-19 ASIC miners.Under the terms of the agreement, Marathon anticipates receiving an initial batch of 7,000 S-19 miners in July 2021 and the final shipment in December 2021. Once all miners are fully deployed, the Company’s mining fleet will consist of more than 103,000 miners capable of producing 10.36 EH/s.   This landscape changing purchase of these miners more than triples the size of Marathon’s existing fleet of 33,000 miners.Marathon’s Chairman and Chief Executive Officer, Merrick Okamoto, stated, “This purchase is the largest order in dollar...

Sjá meðfylgjandi tilkynningu um viðskipti fruminnherja/ fjárhagslega tengdra aðila.ViðhengiSindrandi ehf.

SAN DIEGO, Dec. 28, 2020 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a leading National Security Solutions provider and industry-leading provider of high-performance, jet-powered unmanned aerial systems, announced today that Kratos will receive an additional $3,570,194 from the U.S. Navy for the next option of its Contractor Logistics Support (CLS) and Engineering Services contract supporting BQM-177A aerial target system operations.Steve Fendley, President of Kratos Unmanned Systems Division, said, “Now that we’re beyond the Full Rate Production acquisition milestone, we’ve entered the operations and sustainment phase of the SSAT lifecycle. CLS and Engineering Services are vital to ensuring the continuing adaptation, operations, and maintenance of this agile, realistic, and highly configurable...

NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today reported financial results for its fiscal year ended September 30, 2020.Christopher U Missling, PhD, President and Chief Executive Officer of Anavex said: “Despite all of the new challenges, 2020 was an extraordinary year for Anavex, with significant progress across our portfolio, including our first positive, placebo-controlled, U.S. ANAVEX®2-73 (blarcamesine) Rett syndrome trial, a positive Parkinson’s disease dementia trial, and further progress...

First NDA submission for Company’s lead program, KORSUVA™ Injection –NDA submission includes request for Priority Review under Breakthrough Therapy Designation for KORSUVA Injection –STAMFORD, Conn., Dec. 28, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs, today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for KORSUVA™ Injection (difelikefalin) for the treatment of moderate-to-severe pruritus in hemodialysis patients. KORSUVA Injection received Breakthrough Therapy Designation from the FDA for this indication. Cara has requested Priority Review for the NDA which,...

NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) — Better Choice Company (OTCQB: BTTR) (“Better Choice”), an animal health and wellness company, has qualified to trade on the OTCQX® Best Market. Better Choice Company Inc. upgraded to OTCQX from the OTCQB® Venture Market.Better Choice Company Inc. begins trading today on OTCQX under the symbol “BTTR.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.The OTCQX Market provides investors with a premium U.S. public market to research and trade the shares of investor-focused companies. Graduating to the OTCQX Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among U.S. investors. To qualify for OTCQX, companies must meet high financial standards, follow...